BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23797431)

  • 1. Evaluation of plasma oxidative status in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Icli A; Sutcu R
    Kardiol Pol; 2013; 71(6):588-94. PubMed ID: 23797431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of paraoxonase activity and coronary blood flow.
    Yildiz A; Gur M; Yilmaz R; Demirbag R; Polat M; Selek S; Celik H; Erel O
    Atherosclerosis; 2008 Mar; 197(1):257-63. PubMed ID: 17537444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary flow reserve is impaired in patients with slow coronary flow.
    Erdogan D; Caliskan M; Gullu H; Sezgin AT; Yildirir A; Muderrisoglu H
    Atherosclerosis; 2007 Mar; 191(1):168-74. PubMed ID: 16620834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow.
    Sen N; Ozlü MF; Başar N; Ozcan F; Güngör O; Turak O; Malçok O; Cağli K; Maden O; Erbay AR; Demir AD
    Turk Kardiyol Dern Ars; 2009 Apr; 37(3):168-73. PubMed ID: 19553739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
    Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
    Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma homocysteine level in slow coronary flow.
    Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R
    Int J Cardiol; 2005 May; 101(1):143-5. PubMed ID: 15860399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
    Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
    Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.
    Vassalle C; Botto N; Andreassi MG; Berti S; Biagini A
    Coron Artery Dis; 2003 May; 14(3):213-8. PubMed ID: 12702924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated level of plasma homocysteine in patients with slow coronary flow.
    Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
    Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study.
    Varol E; Gülcan M; Aylak F; Ozaydın M; Sütçü R; Erdoğan D; Doğan A
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):692-7. PubMed ID: 22088857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.
    Evrengul H; Tanriverdi H; Kuru O; Enli Y; Yuksel D; Kilic A; Kaftan A; Kirac S; Kilic M
    Helicobacter; 2007 Aug; 12(4):298-305. PubMed ID: 17669101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mean platelet volume in patients with slow coronary flow.
    Sen N; Basar N; Maden O; Ozcan F; Ozlu MF; Gungor O; Cagli K; Erbay AR; Balbay Y
    Platelets; 2009 Feb; 20(1):23-8. PubMed ID: 19172518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of total oxidative status and total antioxidant capacity in patients with endemic fluorosis.
    Varol E; Icli A; Aksoy F; Bas HA; Sutcu R; Ersoy IH; Varol S; Ozaydin M
    Toxicol Ind Health; 2013 Mar; 29(2):175-80. PubMed ID: 22155887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flow.
    Arbel Y; Sternfeld A; Barak A; Burgansky-Eliash Z; Halkin A; Berliner S; Herz I; Keren G; Rubinstein A; Banai S; Finkelstein A
    Atherosclerosis; 2014 Jan; 232(1):149-54. PubMed ID: 24401229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum uric acid level and coronary blood flow.
    Yildiz A; Yilmaz R; Demirbag R; Gur M; Bas MM; Erel O
    Coron Artery Dis; 2007 Dec; 18(8):607-13. PubMed ID: 18004110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and coronary angiographic characteristics of patients with coronary slow flow.
    Yilmaz H; Demir I; Uyar Z
    Acta Cardiol; 2008 Oct; 63(5):579-84. PubMed ID: 19014000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants.
    Toy H; Camuzcuoglu H; Arioz DT; Kurt S; Celik H; Aksoy N
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1047-53. PubMed ID: 20144170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of microvascular angina with TIMI frame count using nitroprusside induced hyperemia.
    Kim HJ; Hong MK; Kim SH; Chung SM; Chung EJ; Han SW; Ryu KH
    Microvasc Res; 2013 May; 87():95-9. PubMed ID: 23485587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oxidative stress on the development of collateral circulation in total coronary occlusions.
    Demirbag R; Gur M; Yilmaz R; Kunt AS; Erel O; Andac MH
    Int J Cardiol; 2007 Mar; 116(1):14-9. PubMed ID: 16824626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.